Atom | Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline

Funder: National Institutes of Health (NIH)

Due Dates: October 5, 2025 (forecasted)

Funding Amounts: R01 mechanism; award size and total funding not yet specified

Summary: Supports early- to late-stage clinical trials of interventions to prevent or treat cognitive, behavioral, and neuropsychiatric changes in Alzheimer’s disease, related dementias, and age-related cognitive decline.

Key Information: This is a forecasted opportunity; applications are not yet being accepted.

Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline

Sign in to see full grant listing